Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets (Parenthetical)

v3.20.1
Consolidated Balance Sheets (Parenthetical) - USD ($)
Dec. 31, 2019
Dec. 31, 2018
Debt issuance costs, Line of credit $ 15,573 $ 30,000
Common stock, par or stated value per share $ 0.001 $ 0.001
Common stock, shares authorized 250,000,000 250,000,000
Common stock, shares, issued 8,015,756 5,654,830
Common stock, shares, outstanding 8,015,756 5,654,830
Notes Payable [Member]    
Debt issuance costs $ 212,848 $ 0
Convertible Notes Payable [Member]    
Debt issuance costs $ 366,666 $ 466,667